The Patterson Analysis

GW RhythmX's new AI tool, RhythmX Pulse, is now on the Microsoft Marketplace, promising to turn patient conversations into real-time clinical insights for doctors.

Morningstar's 2027 London move to a landmark sustainable office is more than a relocation. It's a strategic play on UK confidence and market synergy.

Apogee Minerals options the advanced Knife Lake copper project, a data-rich asset in a top jurisdiction. It's a bold move, but execution is everything.

Seattle's Sound Pharma completes key Phase 3 enrollment for SPI-1005, putting the first-ever approved drug for debilitating Meniere's disease on the horizon.

The YMCA is mobilizing its 1,200-location network for a single, synchronized event. Is this a PR stunt or a scalable model for tackling social isolation?

At 10, Max Alexander is a TIME100 Creator. But behind the prodigy narrative is a serious business model challenging fashion with sustainable production.

As the secondhand market booms, Plato's Closet's new campaign bets on experiential retail to connect with Gen Z and build real-world confidence.

The appointment of Maj. Gen. Crosier, a key Space Force founder, to TiaLinx's board signals a major shift in how the Pentagon will leverage commercial tech.

A new survey shows MedTech sales reps using AI are 3x more likely to hit quota, yet most are stuck using it for emails. Here's what they're missing.

A national home improvement firm is ditching legacy data silos for a modern AI-ready foundation. It’s a move that reveals the real work behind AI's promise.

Clemson's new small business program is more than a sponsorship deal; it's a blueprint for how local firms can leverage collegiate athletics for real growth.

A new partnership between AI platform Agentio and Meta promises to automate creator advertising, swapping manual deals for data-driven performance.

FTV Capital's #3 global ranking isn't just an award; it's a case study in disciplined, sector-focused investing that outpaces the market. We dissect the playbook.

Delonix Bioworks is running parallel trials in China and Australia for its MenB vaccine, a strategic gambit that could disrupt a billion-dollar market.

With Aon's Q2 results imminent, investors are watching key metrics, strategic moves, and how the firm navigates a complex global risk landscape.

Beyond the grand opening, Crunch's new $12M facility in McKinney reveals a precise strategy to fuse boutique amenities with budget pricing.

United Educators' third consecutive Ward's 50® honor is more than a trophy. It's a critical signal of stability for schools navigating unprecedented risk.

Scientific Games' new ecosystem for the Arizona Lottery isn't just about new games; it's a strategic overhaul set to boost state revenues and modernize a 45-year-old institution.

Argo Infrastructure's latest acquisition of a NuGen solar portfolio is more than a deal; it’s a bellwether for how institutional capital is reshaping the grid.

FusionAuth's new Intelligent MFA and record growth signal a market shift. Companies are rejecting opaque security for transparent, auditable systems they control.